Human COVID-19 immunoglobulin (pH4) for intravenous injection
COVID-19-IVIG-201
Phase 2 mab active
Quick answer
Human COVID-19 immunoglobulin (pH4) for intravenous injection for COVID-19 is a Phase 2 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- mab
- Status
- active